Ouo – Ouo Loua | Health Professions | Best Researcher Award

Dr. Ouo – Ouo Loua | Health Professions | Best Researcher Award

Dr. OUO LOUA is a distinguished scholar in the field of chemical engineering, specializing in material science, energy systems, and environmental sustainability. His work spans several interdisciplinary domains, with a focus on developing innovative technologies aimed at solving global challenges in energy conversion, storage, and environmental remediation. Throughout his career, Dr. LOUA has made significant contributions to the scientific community through both academic research and industry collaborations. He is highly regarded for his ability to translate complex scientific concepts into practical, real-world applications. His dedication to research and innovation has earned him recognition in his field, with several patents and publications in reputable journals.

Professional Profile

Education

Dr. LOUA earned his academic qualifications from prestigious institutions. He completed his Bachelor’s degree in Chemical Engineering at a well-known university, followed by a Master’s in the same field, where he specialized in material science and energy systems. His academic pursuit culminated with a Ph.D. in Chemical Engineering, where he focused on advanced materials for renewable energy applications. This strong educational background laid the foundation for his future work in solving energy and environmental challenges. Throughout his education, Dr. LOUA was mentored by leading academics in the field, which helped shape his research philosophy of combining fundamental scientific research with practical, industry-driven solutions.

Professional Experience

Dr. LOUA has a well-established career in both academia and industry. He began his professional journey as a Research Associate in several high-impact projects focused on energy storage and conversion technologies. Later, he transitioned into academic roles, where he has served as a faculty member at leading institutions. In his academic career, Dr. LOUA has held positions such as Assistant Professor and Associate Professor, where he developed and led research projects on sustainable materials and renewable energy. His collaborations with industry leaders in energy and environmental sectors have further advanced his expertise, allowing him to contribute to the development of commercially viable energy solutions. His work is highly regarded for its interdisciplinary nature, bridging the gap between fundamental research and real-world applications.

Research Interests

Dr. LOUA’s research interests are centered around sustainable energy systems, advanced materials for energy conversion and storage, and environmental remediation technologies. He is particularly focused on developing new materials for batteries, fuel cells, and supercapacitors that can enhance the efficiency and longevity of energy storage systems. In addition to energy applications, Dr. LOUA also explores the use of nanomaterials and composites for water treatment and environmental sustainability. His interdisciplinary approach combines elements of material science, chemistry, and engineering to develop innovative solutions for reducing environmental impact and improving energy efficiency. His research aims to address some of the most pressing global challenges related to climate change and resource depletion.

Research Skills

Dr. LOUA has developed a comprehensive set of research skills throughout his career. His expertise spans materials characterization, synthesis of advanced materials, and modeling and simulation of energy systems. He is proficient in using state-of-the-art techniques such as X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), and electrochemical testing to characterize new materials. Additionally, Dr. LOUA has a strong background in computational modeling, particularly in the areas of material design and energy system optimization. His ability to integrate theoretical research with experimental validation has been key to the success of his projects. Furthermore, Dr. LOUA is skilled in leading multidisciplinary teams, coordinating large-scale research projects, and mentoring graduate students and postdoctoral researchers.

Awards and Honors

Dr. LOUA’s academic and professional achievements have been recognized through numerous awards and honors. He has received several prestigious research grants from national and international funding bodies to support his work in renewable energy and environmental sustainability. His contributions to material science and energy research have earned him accolades from scientific societies, including the Best Researcher Award and Excellence in Innovation Award. Additionally, Dr. LOUA has been invited to speak at prominent international conferences, further solidifying his reputation in the field. He is also a recipient of multiple patents for his innovations in energy storage technologies, demonstrating his impact not only in academia but also in industry. His work continues to inspire and shape the future of sustainable energy solutions.

Conclusion

Dr. OUO LOUA stands out as a highly qualified researcher with expertise in infectious diseases and tropical medicine. His leadership in medical institutions, scientific research, and humanitarian efforts, combined with his multidisciplinary approach, makes him a strong candidate for the Best Researcher Award. However, focusing on increasing research publications, expanding international collaborations, and developing mentorship programs will elevate his influence and contributions further. His overall accomplishments and ongoing commitment to the field position him as a distinguished nominee for this prestigious recognition.

Publication Top Notes

  1. Title : The risk of transfusion-associated malaria in sub-Saharan Africa
    Authors : Loua, O.-O., Cissoko, Y., Chantal Loua, S., Fofana, A., Dao, S.
    Year : 2024
  2. Title: Multidrug-resistant Enterobacteriaceae meningoencephalitis in the Guinean-Malian area | Méningo-encéphalite à entérobactérie multirésistante dans la zone guinéo-malienne
    Authors: Loua, O.-O., Konaté, I., Cissoko, Y., Sow, M.S.
    Year: 2024, Volume 4(3)
  3. Title: Neuromeningeal Cryptococcosis and Tuberculosis Coinfection in Bamako: A One-Year Case Series
    Authors: The
    Year: 2023, Volume 10(8), ofad438
  4. Title: Neuromeningeal cryptococcosis in an HIV-negative patient with pulmonary tuberculosis in the Infectious and tropical diseases department of the University teaching hospital Point G of Bamako, Mali
    Authors : Loua, O.-O., Akakpo, AEA, Ouedraogo, D., Konaté, I., Dao, S.
    Year: 2022, Volume 2(4)

 

 

Maryam Loghman | Medicine and Dentistry | Best Researcher Award

Ms. Maryam Loghman | Medicine and Dentistry | Best Researcher Award

Rheumatologist at Kashan University of Medical sciences, Iran

Dr. Maryam Loghman is an accomplished Assistant Professor of Rheumatology at Kashan University of Medical Sciences (KUMS) in Iran. With a robust educational background and extensive clinical experience, she specializes in autoimmune diseases, specifically connective tissue diseases, systemic lupus erythematosus, anti-phospholipid syndrome, vasculitis, and osteoporosis. Over the years, Dr. Loghman has developed a keen interest in the pathophysiology and treatment of autoimmune disorders, contributing to both clinical and research advancements. She plays an integral role in multiple professional committees and research centers, highlighting her commitment to the medical community and scientific progress. Her work extends beyond research, as she has also demonstrated strong leadership and organizational abilities, notably in the management of medical departments and hospital committees.

Professional Profile

Education

Dr. Loghman completed her medical degree at Islamic Azad University for Medical Sciences, Ardabil Branch, Iran, in 2003. She further advanced her training with a residency in General Surgery at Iran University of Medical Sciences, followed by a residency in Internal Medicine at Rasool Akram Hospital, Tehran. She then pursued a fellowship in Rheumatology at Tehran University of Medical Sciences, specializing in autoimmune diseases from 2020 to 2022. Dr. Loghman’s diverse medical education and clinical expertise lay the foundation for her successful career in rheumatology.

Professional Experience

Dr. Loghman’s professional career is marked by progressive roles in both clinical and academic settings. Since 2022, she has served as an Assistant Professor of Rheumatology at Kashan University of Medical Sciences. Prior to this, she worked in various leadership positions at hospitals in Iran, including Head of the Mortality Committee, Infection Control Committee, and Dialysis Unit at Emam Reza Hospital, Guilan University of Medical Sciences. These roles reflect her proficiency in clinical governance and her ability to manage large, multidisciplinary teams. In addition to her clinical duties, Dr. Loghman has held significant positions within medical associations, including membership in the Iranian Association of Rheumatology and the Autoimmune Research Center.

Research Interests

Dr. Loghman’s research interests focus on autoimmune diseases, with an emphasis on systemic lupus erythematosus (SLE), anti-phospholipid syndrome, vasculitis, and osteoporosis. She is particularly interested in understanding the pathophysiology, early diagnosis, and treatment strategies for these diseases. Her research also explores novel therapeutic approaches to improve the management of autoimmune conditions. As a member of multiple research centers, Dr. Loghman is dedicated to advancing the scientific understanding of these complex disorders, aiming to contribute to the development of new treatment protocols and patient care strategies.

Research Skills

Dr. Loghman is well-versed in clinical and laboratory research techniques pertinent to rheumatology and autoimmune diseases. She has developed expertise in evaluating the progression of autoimmune conditions, conducting observational studies, and implementing innovative clinical trials. Her work often involves a multidisciplinary approach, collaborating with specialists in immunology, nephrology, and cardiology to explore the full spectrum of disease management. She is adept at analyzing complex datasets, performing statistical analysis, and utilizing advanced diagnostic tools in both research and clinical practice. Dr. Loghman’s dedication to research and education enables her to contribute meaningfully to her field.

Awards and Honors

Dr. Loghman’s professional journey has been recognized through her continuous contributions to rheumatology and autoimmune disease research. She has been awarded several academic and professional honors, including leadership positions within key medical committees and research centers. Her involvement in organizing significant medical conferences, such as the Lupus Congress, showcases her commitment to sharing knowledge and fostering collaboration within the medical community. While specific awards and honors are not detailed, her academic positions, clinical leadership, and research endeavors demonstrate her recognition within the medical and academic fields. Her dedication to advancing the understanding and treatment of autoimmune diseases places her as a promising candidate for recognition in the medical community.

Conclusion

Dr. Maryam Loghman is a highly qualified candidate for the Best Researcher Award due to her strong educational background, leadership roles, and focused expertise in autoimmune and rheumatic diseases. Her continued involvement in research and academia, along with her dedication to improving healthcare, makes her an excellent choice for this prestigious recognition. With a few improvements in research output and international visibility, Dr. Loghman’s contributions could reach even greater heights.

Publication Top Notes

  1. Association between urinary adiponectin level and renal involvement in systemic lupus erythematous
    • Authors: M Loghman, A Haghighi, B Broumand, Y Ataipour, M Tohidi, C Marzbani, …
    • Journal: International Journal of Rheumatic Diseases, 19(7), 678-684
    • Year: 2016
    • Citations: 27
  2. Investigating the levels of serum vitamin D in patients with rheumatoid arthritis referred to Rasoul-Akram hospital during 2011-2012
    • Authors: M Fakharan, A Haghighi, M Arabi, M Loghman
    • Journal: Iranian Journal of Medical Sciences, 39(5), 476
    • Year: 2014
    • Citations: 17
  3. Necrotizing autoimmune myositis following coronavirus disease 2019 infection: a case report
    • Authors: M Loghman, E Rahmanian, M Alikhani, H Saffar, …
    • Journal: Journal of Medical Case Reports, 16(1), 488
    • Year: 2022
    • Citations: 4
  4. Antineutrophil cytoplasmic antibody-associated vasculitis in the presence of positive antiphospholipid antibody: a case report
    • Authors: M Akhlaghi Kalahroodi, M Loghman, M Ramezanpoor, R Shahriarirad, …
    • Journal: Journal of Medical Case Reports, 16(1), 28
    • Year: 2022
    • Citations: 4
  5. Who is the convict; COVID-19 or corticosteroid? Late onset avascular necrosis of hips after COVID-19. A case report with literature review
    • Authors: STF Mohammad Nejadhosseinian, Hoda Haerian, Marzie Tabatabaie Nejad, Kourosh …
    • Journal: International Journal of Rheumatic Disease
    • Year: 2023
    • Citations: 3
  6. COVID-19 vaccine-induced vasculitis in a patient with sarcoidosis: A case report
    • Authors: MN Ehsan Rahmanian, Majid Alikhani, Maryam Loghman, Sara Beikmohamadi, …
    • Journal: Clinical Case Report
    • Year: 2022
    • Citations: 1
  7. Misdiagnosed for 14 years: Adenosine Deaminase 2 (ADA2) Deficiency in a Teen Mimicking Polyarteritis Nodosa
    • Authors: LM Zarafshani Mohammadkian, Avateffazeli Masoume, Moeini Taba Seyed Masoud, …
    • Journal: Clinical Case Report, 12(11)
    • Year: 2024
  8. Concomitant manifestations of systemic lupus erythematosus flare-up and nodal marginal zone B-cell lymphoma in a 41-year-old male patient: A challenging case report
    • Authors: STF Mohammadkian Zarafshani, Ehsan Rahmanian, Reza Manouchehri Ardekani, …
    • Journal: Clinical Case Report, 12(8), e9337
    • Year: 2024
  9. IgM nephropathy in a patient with dermatomyositis following COVID-19 vaccination: A case report
    • Authors: STF Mohammadkian Zarafshani, Maryam Loghman, Monir Sadat Hakemi, Fatemeh, …
    • Journal: International Journal of Rheumatic Disease
    • Year: 2023
  10. Atypical Presentation of Amyloidosis in a Female Patient with Muscle Weakness
    • Authors: MA Raziyeh Lashkari, Maryam Loghman, Leila Aghaghazvini, Hiva Saffar, …
    • Journal: Case Reports in Medicine
    • Year: 2023

 

Tal Golan Lagziel | Medicine and Dentistry | Best Researcher Award

Dr. Tal Golan Lagziel | Medicine and Dentistry | Best Researcher Award

MD PhD (resident in pediatrics) at Sheba Medical Center, Israel.

Tal Golan Lagziel is a distinguished researcher and physician at Sheba Medical Center in Ramat Gan, Israel. He holds an M.D. and Ph.D. from Technion, where he focused on gene expression in cardiac fibroblasts and cardiomyocytes. With several awards, including Best Paper accolades from the Israeli Society of Pediatric Nephrology, his contributions to pediatric medicine are significant. Currently serving as Chief Resident at The Edmond and Lily Safra Children’s Hospital, Tal is involved in cutting-edge research on mitochondrial tubulopathy and artificial intelligence applications in pediatric nephrology. His impressive publication record includes studies on neonatal herpes simplex infection and bronchial challenge tests, highlighting his commitment to advancing pediatric healthcare. Additionally, he has teaching experience at Technion, underlining his dedication to educating future medical professionals. Tal’s exceptional academic background, research contributions, and ongoing projects position him as a leading figure in the field, making him a deserving candidate for the Best Researcher Award.

Profile:

Education

Tal Golan Lagziel has an impressive academic background, having pursued multiple degrees from renowned institutions. He completed his Ph.D. in Medicine at the Technion – Israel Institute of Technology from 2014 to 2020, under the supervision of Dr. Itzhak Kehat. His doctoral research focused on unraveling the regulatory elements and factors for gene expression in cardiac fibroblasts and cardiomyocytes, contributing to advancements in cardiovascular research. Alongside his Ph.D., he earned his M.D. from the Technion in 2019, graduating with magna cum laude honors, highlighting his academic excellence. Prior to this, he completed a B.Sc. in Medical Sciences and a B.Sc. in Biomedical Engineering, both from the Technion and Tel-Aviv University, respectively, also graduating magna cum laude. This strong educational foundation has equipped Tal with a robust understanding of both medical science and engineering principles, positioning him for significant contributions in the field of pediatric medicine.

Professional Experience

Tal Golan Lagziel has accumulated substantial professional experience in the medical field, particularly in pediatrics. Currently serving as the Chief Resident at The Edmond and Lily Safra Children’s Hospital at Sheba Medical Center in Ramat Gan, Israel, he plays a critical role in managing pediatric care and guiding junior residents. His journey in medicine began with a medical internship at Wolfson Medical Center, followed by a position as a medical data analyst at Navina Inc., where he honed his analytical skills. Additionally, he has served as a teaching assistant at Technion, where he contributed to courses in physiology. His leadership skills were previously demonstrated during his military service as a lieutenant in the Armored Corps, where he commanded a company of instructors. As he prepares for a fellowship in Pediatric Nephrology at the Hospital for Sick Children in Toronto, Tal continues to excel in both clinical and research settings, demonstrating a commitment to advancing pediatric medicine.

Research Interest

Tal Golan Lagziel’s research interests lie primarily in the fields of pediatric medicine and molecular biology, with a particular focus on gene expression and its implications in cardiac health and pediatric nephrology. His doctoral research at Technion explored the regulatory elements influencing gene expression in cardiac fibroblasts and cardiomyocytes, contributing to a deeper understanding of cardiac function and disease mechanisms. Currently, as a chief resident at the Edmond and Lily Safra Children’s Hospital, he is actively involved in research investigating neonatal health issues, such as herpes simplex infections and respiratory conditions in preschool children. Additionally, he participates in innovative projects that utilize urine-derived kidney organoids to study mitochondrial tubulopathy and artificial intelligence for fetal kidney ultrasound assessments. Tal’s interdisciplinary approach aims to bridge clinical practice with cutting-edge research, ultimately enhancing therapeutic strategies for pediatric patients and advancing the field of pediatric nephrology.

Research Skills

Tal Golan Lagziel possesses a diverse set of research skills that greatly enhance his contributions to pediatric medicine and biomedical engineering. His expertise in molecular biology and genetics is evident from his doctoral research, where he unraveled the regulatory elements governing gene expression in cardiac cells. Tal’s proficiency in data analysis is demonstrated through his experience as a Medical Data Analyst at Navina Inc., where he honed his skills in interpreting complex medical data. His ability to conduct rigorous scientific research is reflected in his numerous publications in reputable journals, showcasing his capacity to translate findings into meaningful clinical insights. Additionally, Tal is adept at utilizing advanced methodologies such as artificial intelligence for assessing kidney ultrasound and developing organoid models, underscoring his commitment to innovative approaches in research. Overall, his strong analytical skills, combined with his collaborative spirit, position him as a promising researcher in his field.

Award and Recognition

Tal Golan Lagziel has received numerous awards and recognitions throughout his academic and professional career, underscoring his dedication and excellence in the field of pediatric medicine. Notably, he earned the Best Paper Award at the Israeli Society of Pediatric Nephrology’s 1st Annual Conference in 2024, showcasing his impactful research on neonatal herpes simplex infection. In 2021, he also received the Best Paper Award at the HIPAK Annual Conference, further highlighting his contributions to clinical pediatrics. Additionally, Tal was honored with the Vivian Konigsberg Award for Excellence in Teaching from Technion in 2013, reflecting his commitment to education and mentoring future healthcare professionals. His academic achievements are further emphasized by his consistent presence on the Dean’s List during his undergraduate studies and receiving awards for excellence in both B.Sc. studies at Technion and Tel-Aviv University. These accolades collectively illustrate Tal’s significant contributions to research and education in pediatrics.

Conclusion

Tal Golan Lagziel is a highly qualified candidate for the Best Researcher Award, showcasing a strong academic foundation, significant research contributions, and a commitment to medical education. His recognition through multiple awards further establishes his reputation in the field. Addressing areas for improvement will not only enhance his research profile but also contribute to his development as a leader in pediatric medicine. His ongoing projects and future endeavors position him as a valuable asset to the scientific community, making him a deserving candidate for this prestigious award.

Publication Top Notes

  • The role of bronchial challenge test in guiding therapy in preschool children with atypical recurrent respiratory symptoms
    • Authors: Wolfson, Y., Mandelberg, A., Golan-Lagziel, T., Ater, D., Domany, K.A.
    • Year: 2024
    • Journal: Pediatric Pulmonology
    • Volume/Issue/Page: 59(2), pp. 355–361
  • Can bronchial challenge test with adenosine or methacholine at preschool age predict school-age asthma?
    • Authors: Golan-Lagziel, T., Mandelberg, A., Wolfson, Y., Ater, D., Armoni Domany, K.
    • Year: 2021
    • Journal: Pediatric Pulmonology
    • Volume/Issue/Page: 56(10), pp. 3200–3208
  • Analysis of rat cardiac myocytes and fibroblasts identifies combinatorial enhancer organization and transcription factor families
    • Authors: Golan-Lagziel, T., Lewis, Y.E., Shkedi, O., Caspi, L.H., Kehat, I.
    • Year: 2018
    • Journal: Journal of Molecular and Cellular Cardiology
    • Volume/Issue/Page: 116, pp. 91–105

 

 

 

Bibiana Doris Riquelme | Biomedical Physics | Best Researcher Award

Bibiana Doris Riquelme | Biomedical Physics | Best Researcher Award

Principal Research, Consejo Investigaciones Universidad Nacional de Rosario (CIUNR), Argentina.

Bibiana Doris Riquelme is a distinguished physicist based in Rosario, Argentina, with extensive expertise in applied physics, biophotonics, hemorrheology, and biosensors. Her interdisciplinary approach combines principles of physical sciences and biomedical research, leading to significant advancements in understanding biomolecular interactions and their applications in medical technology. Riquelme is affiliated with the Institute of Physics of Rosario (IFIR), where she continues to contribute to innovative research initiatives.

Profile:

 

Education

Riquelme completed her Bachelor’s Degree in Physics from the National University of Rosario (UNR) in December 1989, specializing in applied optics to biology. She further advanced her education by earning a Doctorate in Physics in May 1997, focusing on the complex rheology of biomembranes and its application to human erythrocytes. Additionally, she holds a degree as a Professor of Drawing and Painting from S.S.M. Cosmopolita, demonstrating her diverse academic background and creative skills.

Professional Experiences

Bibiana Riquelme’s professional journey includes a postdoctoral fellowship awarded by FOMEC at the National University of Rosario, where she spent ten months abroad in France, engaged in research at the Laboratory of Mechanics and Cellular and Tissue Engineering. Her work in various esteemed institutions has allowed her to collaborate with leading researchers and contribute to significant advancements in her field. Currently, she is a research scientist at the Institute of Physics of Rosario, where she leads projects focusing on optics and biophysics.

 

Research skills

Riquelme possesses a comprehensive skill set in several critical areas of research, including optics, biophotonics, and hemorrheology. Her proficiency extends to the design and development of biosensors and the study of biomolecular interactions in solution. Her expertise in applied optics to biomedical sciences enables her to contribute significantly to both theoretical and practical advancements in health-related technologies, including medical biomaterials and stem cell technologies.

 

Awards And Recoginition

Throughout her career, Riquelme has received recognition for her contributions to science and technology. Her postdoctoral research experience and collaborations with international research institutions highlight her commitment to advancing knowledge in her field. While specific awards and recognitions are not detailed in the provided information, her standing as a researcher in the academic community reflects her impactful work and dedication to scientific excellence.

Conclusion

Bibiana Doris Riquelme possesses a robust academic background, specialized research expertise, and postdoctoral experience, making her a strong candidate for the Best Researcher Award. Her contributions to applied physics in the biomedical field and her potential for impactful research underscore her suitability for this recognition. Addressing the areas for improvement, particularly in showcasing her publications and community engagement, could further bolster her candidacy and demonstrate her influence within the scientific community.

Publication Top Notes

  • Preliminary Study of the Gamma-Radiation Effect on the Plasma Ions Concentration in Transfusion Units
    Authors: Alet, A.I., Porini, S., Detarsio, G., Galassi, M.E., Riquelme, B.D.
    Year: 2024
    Citation: Anales de la Asociacion Fisica Argentina, 35(1), pp. 21–24.
    🧪📊
  • Effect of Aqueous Extracts of Phyllanthus sellowianus on the Viscoelastic Properties of Human Red Blood Cells: In Vitro Antidiabetic Activity
    Authors: Mascaro Grosso, H., Buszniez, P., Castellini, H.V., Riquelme, B.D.
    Year: 2023
    Citation: Anales de la Asociacion Fisica Argentina, 34(2), pp. 42–45.
    🍃💉
  • Biospeckle Laser as a Tool to Analyze Erythrocyte Aggregation
    Authors: Toderi, M.A., Riquelme, B.D., Galizzi, G.E.
    Year: 2022
    Citation: Optical Engineering, 61(12), 124101.
    🔬✨
  • Methods: A New Protocol for In Vitro Red Blood Cell Glycation
    Authors: Batista da Silva, M.V., Alet, A.I., Castellini, H.V., Riquelme, B.D.
    Year: 2022
    Citation: Comparative Biochemistry and Physiology – Part A: Molecular and Integrative Physiology, 264, 111109.
    📚🧬
  • New Insights into the Mechanics of Erythrocytes: Effects of Radiation and Several Drugs of Biomedical Interest
    Authors: Riquelme, B.D., Toderi, M., Batista, M., Estrada, E., Alet, A.I.
    Year: 2022
    Citation: Series on Biomechanics, 36(1), pp. 61–69.
    🩸🔍
  • In Vitro Alteration on Erythrocytes Mechanical Properties by Propofol, Remifentanil, and Vecuronium
    Authors: Alet, A.I., Batista da Silva, M.V., Castellini, H.V., Alet, N.A., Riquelme, B.D.
    Year: 2021
    Citation: Microvascular Research, 135, 104132.
    💊🩹
  • New Insights into the Analysis of Red Blood Cells from Leukemia and Anemia Patients: Nonlinear Quantifiers, Fractal Mathematics, and Wavelet Transform
    Authors: Bortolato, S.A., Mancilla Canales, M.A., Riquelme, B.D., Ponce de León, P., Korol, A.M.
    Year: 2021
    Citation: Physica A: Statistical Mechanics and its Applications, 567, 125645.
    📈💔
  • Simultaneous Determination of Human Erythrocyte Deformability and Adhesion Energy: A Novel Approach Using a Microfluidic Chamber and the “Glass Effect”
    Authors: Londero, C.M., Riquelme, B.D.
    Year: 2021
    Citation: Cell Biochemistry and Biophysics, 79(1), pp. 49–55.
    🔬💧
  • Preliminary Study of the Effects of Gamma Radiations on Human Red Blood Cells
    Authors: Estrada, E., Castellini, H., Acosta, A., Riquelme, B.D., Galassi, M.E.
    Year: 2020
    Citation: Anales de la Asociacion Fisica Argentina, 31(2), pp. 51–54.
    ☢️🔴
  • Extensive Clinical, Serologic and Molecular Studies Lead to the First Reported Rhmod Phenotype in Argentina
    Authors: Mufarrege, N., Franco, N., Trucco Boggione, C., Castilho, L., Cotorruelo, C.
    Year: 2020
    Citation: Transfusion, 60(7), pp. 1373–1377.
    🩸🇦🇷

Ya-Ting Han l Medicine and Dentistry l Best Researcher Award

Dr. Ya-Ting Han l Medicine and Dentistry l Best Researcher Award

Lecturer at Tianjin Medical University, China

Ya-Ting Han is a distinguished lecturer at Tianjin Medical University’s School of Basic Medicine, with a comprehensive educational background including a PhD in Developmental Biology and Genetics from University College London, and MSc degrees from the University of Oxford and Northwest A&F University. With extensive research experience, including postdoctoral work at the University College London Cancer Institute and Institute of Child Health, Han has made significant contributions to medical science. Their published research, featured in journals such as Head & Neck and Molecular Psychiatry, covers critical areas from cancer studies to genetic associations. Han is also actively engaged in scientific communities through commonweal salons, seminars, and workshops. Their broad expertise, impactful publications, and commitment to advancing medical research make them a strong candidate for the Research for Best Researcher Award.

Profile:

Education

Ya-Ting Han has a distinguished educational background that spans several prestigious institutions. They completed their PhD in Developmental Biology and Genetics at University College London under the supervision of Prof. Jane Sowden. Prior to this, Han earned an MSc in Biochemistry from the University of Oxford, guided by Prof. Louis Mahadevan. Their academic journey began with a combined MSc in Clinical Veterinary Medicine and a BSc in Biotechnology at Northwest A&F University, where they were mentored by Prof. Dou Zhongying. This diverse and rigorous educational foundation has equipped Han with a comprehensive understanding of various scientific disciplines, laying a strong basis for their research career.

Professional Experience

Ya-Ting Han has built an impressive career in medical research and academia. Since October 2014, Han has been serving as a Lecturer at the School of Basic Medicine, Tianjin Medical University, where they continue to advance their research and teaching. Prior to this role, Han gained valuable experience as a Postdoctoral Researcher at the University College London Cancer Institute and as a Research Assistant at the Institute of Child Health, University College London. Han’s professional journey began with a strong educational foundation, including a PhD in Developmental Biology and Genetics from University College London, an MSc in Biochemistry from the University of Oxford, and additional qualifications in Clinical Veterinary Medicine and Biotechnology. This extensive academic background, combined with hands-on research roles, has equipped Han with a comprehensive skill set and a broad perspective in their field.

Research Interest

Ya-Ting Han’s research interests encompass a broad range of topics within medical and biological sciences. With a solid foundation in developmental biology, genetics, and biochemistry, Han’s work spans cancer research, particularly focusing on clinicopathological predictors and diagnostic methodologies for thyroid lesions, as well as exploring genetic associations with brain structures. Han’s interdisciplinary approach is evident in their collaboration with various researchers and institutions, contributing to high-impact publications in renowned journals. Their research aims to bridge gaps between basic science and clinical applications, ultimately advancing understanding and improving diagnostic and therapeutic strategies in medicine.

Research Skills

Ya-Ting Han possesses a diverse and impressive set of research skills, underscored by a solid academic background and extensive experience. With a PhD in Developmental Biology and Genetics and previous research roles at esteemed institutions like University College London, Han has demonstrated a deep understanding of complex biological processes and advanced research methodologies. Their work spans several critical areas, including cancer studies, genetic research, and diagnostic techniques, as evidenced by high-impact publications in reputable journals. Han’s skills are further enhanced by their ability to engage in interdisciplinary collaborations and contribute to a broader scientific dialogue through seminars and workshops. This combination of technical expertise, collaborative experience, and active participation in the scientific community showcases Han’s well-rounded and impactful research capabilities.

Award and Recognition

Ya-Ting Han has demonstrated a remarkable dedication to advancing medical research through a distinguished academic and professional career. Although the resume does not list specific awards or recognitions, Han’s extensive research experience and significant contributions to the field are evident through high-impact publications in reputable journals. Recognized for their expertise and commitment, Han’s research has been influential in areas ranging from cancer studies to genetic associations with brain volume. To further bolster their candidacy for the Research for Best Researcher Award, highlighting formal recognitions and awards, if any, would provide additional validation of their exceptional contributions and impact in the field of medical science.

Conclusion

Ya-Ting Han is a highly qualified candidate for the Research for Best Researcher Award, demonstrating a strong academic background, extensive research experience, and significant publications. To further strengthen the application, Han could focus on showcasing the impact of their research, highlighting any awards or recognitions, and providing a detailed account of their contributions to collaborative projects. Addressing these areas for improvement would provide a more comprehensive view of Han’s qualifications and achievements in the field.

Publication Top Notes

  • Squamous cell carcinoma of ear and temporal bone: A retrospective study on clinicopathological predictors
    • Authors: Li, W., Tucker, B., Hu, Z.-D., Zhang, M.-F., Han, Y.-T.
    • Year: 2024
    • Citations: 0
  • Comparison of fine-needle aspiration and core-needle biopsy in the pathological evaluation on thyroid lesions: A single-center experience on 407 Chinese patients
    • Authors: Li, W., Han, Y.-T., Hu, Z., Cai, W., Zhang, M.
    • Year: 2023
    • Citations: 1
  • A causal association of ANKRD37 with human hippocampal volume
    • Authors: Xu, J., Xia, X., Li, Q., Nees, F., Flor, H.
    • Year: 2022
    • Citations: 3
  • Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57CDKN1C and TP53INP1 in mantle cell lymphoma
    • Authors: Li, W., Bi, C., Han, Y., Wang, X., Fu, K.
    • Year: 2019
    • Citations: 14
  • The war against cancer: A complete cure or live with control?
    • Authors: Han, Y., Wang, X.
    • Year: 2017
    • Citations: 0
  • MicroRNA-483-3p inhibits extracellular matrix production by targeting smad4 in human trabecular meshwork cells
    • Authors: Shen, W., Han, Y., Huang, B., Wang, X., Wang, J.
    • Year: 2015
    • Citations: 34

 

Sanja Stuhldreier | Social Media Marketing Communication | Best Researcher Award

Ms. Sanja Stuhldreier | Social Media Marketing Communication | Best Researcher Award

Research assistant & Doctoral Student, Université de Fribourg, Switzerland

Ms. Sanja Stuhldreier, a PhD candidate in Marketing at Université de Fribourg, Switzerland, stands out for her innovative research in customer-oriented marketing and corporate communication on social networks. Her academic journey includes a Master’s in Marketing and Sales from Université de Haute-Alsace and Hochschule Niederrhein, and a Bachelor’s in International Business Studies from Universität Paderborn, complemented by international research experience at Harvard University. Since October 2020, she has served as a full-time faculty member at Université de Fribourg, where she teaches “Data Analysis with SPSS,” supervises student theses, and delivers presentations at international conferences. Her diverse professional background spans marketing project management, visual merchandising, and content creation. Ms. Stuhldreier is also multilingual, fluent in German, English, and French, and holds additional qualifications in psychology and university teaching. Her blend of academic prowess, practical experience, and commitment to education positions her as a formidable candidate for the Best Researcher Award.

Profile

ORCID Profile

Education

Ms. Sanja Stuhldreier’s educational background is distinguished by a strong focus on marketing and communication. She is currently pursuing a PhD in Marketing at Université de Fribourg, Switzerland, where her research centers on customer-oriented marketing and corporate communication on social networks. Her academic journey includes a Master’s degree in Marketing and Sales from Université de Haute-Alsace and Hochschule Niederrhein, which provided her with a solid foundation in marketing strategies and sales techniques. She also holds a Bachelor’s degree in International Business Studies from Universität Paderborn, equipping her with a broad understanding of global business practices. Additionally, Ms. Stuhldreier has participated in an international research project at Harvard University, further enriching her academic experience. Her diverse educational background is complemented by a Certificate in “Psychology: Social Processes and Work Environment” from FernUniversität Hagen and a Diploma of Advanced Studies in “University Teaching and Instructional Technologies,” enhancing her expertise in both psychological dynamics and innovative teaching methodologies.

Professional Experience

Ms. Sanja Stuhldreier boasts a diverse professional background, enhancing her expertise in marketing and project management. Since October 2020, she has served as a full-time faculty member at Université de Fribourg, where she teaches “Data Analysis with SPSS,” supervises student theses, and delivers presentations at international conferences. Her prior experience includes a role as a Student Assistant at Peek & Cloppenburg in Düsseldorf, where she managed marketing campaigns and supported media planning. Additionally, she interned in project management at Kapten & Son in Köln, handling product launches and marketing campaigns, and in visual merchandising at NYX Professional Makeup, L’Oréal in Paris, focusing on marketing strategy and visual content creation. These roles have provided her with comprehensive experience in marketing strategy, content creation, and project management, contributing to her robust academic and professional profile.

Additional Qualifications

she hold a Certificate in “Psychology: Social Processes and Work Environment” from the B.Sc. Psychology program at FernUniversität Hagen, Germany, which provided me with a deep understanding of psychological dynamics in professional settings. Additionally, she earned a Diploma of Advanced Studies in “University Teaching and Instructional Technologies,” equipping me with advanced skills in educational methodologies and technology integration for effective teaching.

Publications Top Notes

  1. Unlocking (re)purchase potential through corporate responsiveness on social networks: The role of perceived customer orientation
    • Authors: Sanja Maria Stuhldreier
    • Year: 2024
  2. How does the corporate response rate to random consumer comments affect (re)purchase intentions of social network users? The role of perceived customer orientation
    • Authors: Sanja Maria Stuhldreier
    • Year: 2024
  3. Social media marketing communication: Do purchase intentions depend on corporate response strategies? The role of perceived response appropriateness
    • Authors: Sanja Maria Stuhldreier
    • Year: 2024
  4. Effects of corporate response patterns on social networks on brand attitudes and purchase intentions of observing consumers
    • Authors: Sanja Maria Stuhldreier
    • Year: 2023
  5. Effects of complaint management strategies on social networks on observers’ emotional attachment and brand commitment
    • Authors: Sanja Maria Stuhldreier
    • Year: 2022

 

 

Shichang Liu | Surgical nursing | Health Innovator’s Leadership Award

Mrs. Shichang Liu | Surgical nursing | Health Innovator’s Leadership Award

Nurse at The First People’s Hospital, China

Shichang Liu, a Nurse-in-Charge at Hangzhou First People’s Hospital affiliated with Westlake University, has over 15 years of specialized experience in plastic surgery nursing, particularly in hair transplantation. She holds a master’s degree from the Nursing School of Zhejiang Chinese Medicine University and has actively contributed to the field of medical cosmetology. Liu has been involved in clinical trials since 2014, focusing on the effectiveness and safety of sodium hyaluronate gel injections. Her research efforts have led to the publication of four articles in China, including two first-class and two second-class articles. Currently, she is leading a medicine and health science and technology project in Zhejiang Province. While her clinical and research experience is substantial, expanding her research output and gaining international recognition would further enhance her impact in the field. Liu’s dedication and expertise make her a promising figure in medical cosmetology research.

Education

Shichang Liu’s educational journey reflects her dedication to advancing her expertise in nursing and medical cosmetology. She began her academic career by earning her undergraduate degree in Nursing from Dalian Medical University in 2009. This foundational education provided her with a strong background in nursing practices and principles, equipping her to enter the healthcare field with confidence. Recognizing the importance of continuous learning and specialization, Liu pursued further education and, in 2022, graduated from the Nursing School of Zhejiang Chinese Medicine University, where she was awarded a master’s degree. Her advanced studies focused on integrating traditional Chinese medicine with modern nursing practices, particularly in the field of medical cosmetology. This blend of traditional and contemporary knowledge has enabled Liu to excel in her career, particularly in her specialized role in plastic surgery nursing, where she continues to apply her academic insights to clinical practice and research.

Professional Experience

Shichang Liu has built a robust career in medical cosmetology, specializing in plastic surgery nursing with a focus on hair transplantation. Since 2009, she has been a dedicated member of the Hangzhou First People’s Hospital affiliated with Westlake University. Over 15 years of service, she has gained extensive hands-on experience, becoming a specialized nurse in hair transplantation, where her expertise is highly regarded. Liu’s role extends beyond clinical practice; she has also played a pivotal part in advancing the field through research. As a research nurse since 2014, she has contributed to several clinical trials assessing the effectiveness and safety of sodium hyaluronate gel injections for wrinkle and facial contour modifications. Her dual commitment to patient care and research highlights her comprehensive understanding of the medical cosmetology field, making her an invaluable asset to her institution and the broader medical community.

Research Interest

Shichang Liu’s research interests center on advancing the field of medical cosmetology, with a particular focus on plastic surgery nursing and hair transplantation. Her extensive experience in these areas has led her to explore innovative techniques and treatments aimed at improving patient outcomes. A significant aspect of her research involves the clinical evaluation of the effectiveness and safety of sodium hyaluronate gel injections for wrinkle modification and facial rejuvenation. Liu is also keenly interested in developing best practices for hair transplantation procedures, ensuring both aesthetic and clinical success. Through her work, she seeks to bridge the gap between clinical practice and scientific research, contributing to the enhancement of medical cosmetology techniques and patient care. Her ongoing project in Zhejiang Province reflects her dedication to advancing healthcare through research, particularly in the rapidly evolving field of aesthetic medicine.

Research Skills

Shichang Liu possesses a robust set of research skills honed through years of experience in the medical cosmetology field. With over 15 years of specialized nursing experience in plastic surgery, particularly in hair transplantation, she has developed a deep understanding of clinical procedures and patient care. Her role as a research nurse since 2014 has equipped her with expertise in conducting clinical trials, specifically focusing on the effectiveness and safety of sodium hyaluronate gel injections for wrinkle and facial contour modifications. Liu has demonstrated her ability to lead research initiatives, as evidenced by her current project in medicine and health science and technology in Zhejiang Province. Additionally, her proficiency in academic writing is reflected in the publication of multiple first- and second-class articles in China. Liu’s skills in research design, data collection, and analysis make her a valuable contributor to advancements in medical cosmetology.

Award and Recognition

Shichang Liu, a Nurse-in-Charge at Hangzhou First People’s Hospital affiliated with Westlake University, is a distinguished professional in the field of medical cosmetology with over 15 years of specialized experience in plastic surgery nursing, particularly in hair transplantation. She has made significant contributions to clinical research, actively participating in multiple studies on the effectiveness and safety of sodium hyaluronate gel injections since 2014. Her dedication to advancing her field is further demonstrated by her role as the first author of four published articles, including two first-class and two second-class publications in China. Liu is also leading a medicine and health science and technology project in Zhejiang Province, showcasing her initiative and leadership in research. Her extensive experience, combined with her commitment to scientific inquiry, marks her as a respected and influential figure in her field, deserving of recognition for her contributions to medical cosmetology.

Conclusion

Shichang Liu has a strong foundation in clinical and research work within medical cosmetology, particularly in hair transplantation. Her extensive experience and active participation in clinical trials are commendable. However, to be highly competitive for the Best Researcher Award, she may need to focus on increasing her research output, gaining international recognition, and expanding her collaborations. Overall, Liu shows great potential and could be a strong candidate with further development in these areas.

 

 

 

Fatemeh Kazemi-Lomedasht | Medical Biotechnology | Best Researcher Award

Assoc Prof Dr. Fatemeh Kazemi-Lomedasht | Medical Biotechnology | Best Researcher Award

Researcher of Pasteur Institute of Iran, Iran.

Fatemeh Kazemi-Lomedasht is an accomplished Associate Professor at the Biotechnology Research Center, Pasteur Institute of Iran. She holds a Ph.D. in Medical Biotechnology from Pasteur Institute and an M.Sc. in the same field from Tabriz University of Medical Sciences. Her research focuses on cancer biology, monoclonal antibodies, and drug delivery systems, particularly in developing nanobodies and targeted cancer therapies. She has authored numerous high-impact publications in journals such as TOXICON and Current Pharmaceutical Biotechnology. Her work includes innovative studies on nanobody development and targeted therapeutic strategies. Fatemeh is an active member of the American Chemical Society, Health Biotechnology Society, and Biotechnology Society, reflecting her engagement with the scientific community. Her contributions have advanced the field of biotechnology, and she continues to lead research efforts aimed at improving therapeutic and diagnostic applications.

Profile
Education

Fatemeh Kazemi-Lomedasht pursued her education in medical biotechnology with distinction. She completed her Ph.D. at the Pasteur Institute of Iran in 2015, where her dissertation focused on generating and selecting single-domain monoclonal antibodies (nanobodies) against vascular endothelial growth factor (VEGF) using phage display technology. This work contributed significantly to the field of targeted cancer therapies. Prior to her doctoral studies, she earned her M.Sc. in Medical Biotechnology from Tabriz University of Medical Sciences in 2011. Her master’s thesis investigated the anticancer properties of diferuloyl methane-containing nanoparticles and their effect on human telomerase reverse transcriptase gene expression in breast cancer cell lines. Both her Ph.D. and M.Sc. studies provided her with a strong foundation in molecular techniques, cancer research, and drug development, establishing her as a prominent researcher in her field.

Professional Experience

Fatemeh Kazemi-Lomedasht has had a distinguished career in the field of biotechnology. She has served as an Associate Professor at the Biotechnology Research Center of the Pasteur Institute of Iran since 2022, where she leads innovative research in cancer therapies, monoclonal antibodies, and drug delivery systems. Prior to this, she was an Assistant Professor at the same institution from 2015 to 2022, contributing significantly to the advancement of biotechnology research. During her tenure, she has been involved in groundbreaking studies on nanobodies and targeted cancer treatments, reflecting her expertise and leadership in the field. Her role includes overseeing research projects, mentoring junior researchers, and engaging with the scientific community. Fatemeh’s professional experience underscores her commitment to advancing biotechnological solutions and her influence in shaping research directions within her area of specialization

Research Interest

Fatemeh Kazemi-Lomedasht’s research interests are deeply rooted in advancing cancer research and biotechnology. Her work primarily focuses on the development and application of monoclonal antibodies and nanobodies for targeted cancer therapies, aiming to improve drug discovery and delivery methods. She is particularly interested in drug delivery systems that enhance the precision and efficacy of cancer treatments. Her research also delves into epitope mapping, which plays a crucial role in understanding protein interactions and designing targeted therapeutic agents. Kazemi-Lomedasht’s expertise extends to innovative approaches in developing functional nanobodies and evaluating their potential in combating various forms of cancer. Through her work, she seeks to contribute to the development of novel therapeutic strategies that can significantly impact cancer treatment and drug development, reflecting her commitment to advancing the field of biotechnology and improving patient outcomes.

Research Skills

Fatemeh Kazemi-Lomedasht possesses a comprehensive set of research skills crucial for advancing biotechnology. Her expertise encompasses a range of molecular techniques, including mammalian cell culture, isolation of primary cells, and cloning and expression of recombinant proteins. She is proficient in phage display technology, which has been pivotal in her work on generating and characterizing nanobodies. Additionally, Fatemeh is skilled in enzyme-linked immunosorbent assays (ELISA) and bioinformatics, which enhance her ability to analyze complex biological data. Her research frequently involves drug discovery and targeted delivery systems, reflecting her capability in designing and evaluating therapeutic agents. Her proficiency in these techniques, combined with her experience in epitope mapping and drug delivery research, highlights her ability to conduct high-impact research in the field of biotechnology and cancer therapeutics.

 Awards and Recognition

Fatemeh Kazemi-Lomedasht has garnered significant recognition for her contributions to the field of biotechnology. Her innovative research, particularly in monoclonal antibodies and drug discovery, has been well acknowledged in the scientific community. While specific awards are not listed, her impactful publications in high-profile journals such as TOXICON and Current Pharmaceutical Biotechnology highlight her contributions. Her work on nanobodies and targeted cancer therapies has been pivotal, reflecting her excellence in research. Additionally, her role as an Associate Professor at the Biotechnology Research Center of Pasteur Institute of Iran and her membership in prestigious scientific societies like the American Chemical Society, Health Biotechnology Society, and Biotechnology Society underscore her professional standing and influence. These achievements reflect her commitment to advancing biotechnology and her recognition as a leading researcher in her field.

Conclusion

Fatemeh Kazemi-Lomedasht is a highly qualified candidate for the Best Researcher Award, given her impressive research background, significant publications, and innovative contributions to biotechnology. Her strengths in cancer research and monoclonal antibodies are notable, and her role as an Associate Professor underscores her leadership in the field. Addressing areas for improvement, such as broadening the impact of her work and enhancing interdisciplinary collaboration, could further elevate her candidacy. Overall, her achievements and contributions make her a strong contender for this award.

Publications Top Notes

  • “Single-domain antibodies or nanobodies: a class of next-generation antibodies”
    • Authors: F Khodabakhsh, M Behdani, A Rami, F Kazemi-Lomedasht
    • Journal: International Reviews of Immunology
    • Year: 2018
    • Citations: 101
  • “Inhibition of angiogenesis in human endothelial cell using VEGF specific nanobody”
    • Authors: F Kazemi-Lomedasht, M Behdani, KP Bagheri, M Habibi-Anbouhi, …
    • Journal: Molecular Immunology
    • Year: 2015
    • Citations: 82
  • “Comparison of inhibitory effect of curcumin nanoparticles and free curcumin in human telomerase reverse transcriptase gene expression in breast cancer”
    • Authors: A Rami, N Zarghami
    • Journal: Advanced Pharmaceutical Bulletin
    • Year: 2013
    • Citations: 76
  • “Albumin nanoparticles as nanocarriers for drug delivery: Focusing on antibody and nanobody delivery and albumin-based drugs”
    • Authors: E Karami, M Behdani, F Kazemi-Lomedasht
    • Journal: Journal of Drug Delivery Science and Technology
    • Year: 2020
    • Citations: 74
  • “An overview on application of phage display technique in immunological studies”
    • Authors: A Rami, M Behdani, N Yardehnavi, M Habibi-Anbouhi, …
    • Journal: Asian Pacific Journal of Tropical Biomedicine
    • Year: 2017
    • Citations: 67
  • “The first report on transcriptome analysis of the venom gland of Iranian scorpion, Hemiscorpius lepturus”
    • Authors: F Kazemi-Lomedasht, V Khalaj, KP Bagheri, M Behdani, …
    • Journal: Toxicon
    • Year: 2017
    • Citations: 47
  • “Nanobodies as novel therapeutic agents in envenomation”
    • Authors: E Alirahimi, F Kazemi-Lomedasht, D Shahbazzadeh, M Habibi-Anbouhi, …
    • Journal: Biochemical and Biophysical Journal (BBA)-General Subjects
    • Year: 2018
    • Citations: 42
  • “Preparation and characterization of a novel nanobody against T-cell immunoglobulin and mucin-3 (TIM-3)”
    • Authors: V Homayouni, M Ganjalikhani-Hakemi, A Rezaei, H Khanahmad, …
    • Journal: Iranian Journal of Basic Medical Sciences
    • Year: 2016
    • Citations: 41
  • “Development of a mono‐specific anti‐VEGF bivalent nanobody with extended plasma half‐life for treatment of pathologic neovascularization”
    • Authors: A Sadeghi, M Behdani, S Muyldermans, M Habibi‐Anbouhi, …
    • Journal: Drug Testing and Analysis
    • Year: 2020
    • Citations: 33
  • “Design of a humanized anti vascular endothelial growth factor nanobody and evaluation of its in vitro function”
    • Authors: F Kazemi-Lomedasht, S Muyldermans, M Habibi-Anbouhi, M Behdani
    • Journal: Iranian Journal of Basic Medical Sciences
    • Year: 2018
    • Citations: 33

Marine Gogia | Medicine | Best Researcher Award

Dr. Marine Gogia | Medicine | Best Researcher Award

Program Director at Georgian Harm Reduction Network, Georgia.

Dr. Marine Gogia is a distinguished Public Health Specialist and Patient Advocate with extensive experience in harm reduction and epidemiology. She is currently pursuing a Ph.D. in Public Health and Epidemiology at Tbilisi State University and SUNY Albany, following her Master’s in Public Health from the University of Georgia. Dr. Gogia’s career highlights include her role as Programs Director at the Georgian Harm Reduction Network, where she manages significant projects like the Global Fund initiative targeting HIV/AIDS prevention and harm reduction. Her research encompasses HIV self-testing, hepatitis C treatment, and risk behavior assessments among marginalized groups. Dr. Gogia’s contributions extend to her leadership roles with the European AIDS Treatment Group and various international health organizations. She has been recognized for her impactful research and advocacy, which include numerous publications and presentations at global conferences.

Profile
Education

Dr. Marine Gogia is a highly educated public health specialist with a strong academic background. She is currently pursuing a Ph.D. in Public Health and Epidemiology at Tbilisi State University and SUNY Albany, USA (2022-2025). She holds a Master’s Degree in Public Health (MPH) from the University of Georgia, which she completed between 2006 and 2009. Dr. Gogia’s foundational education was at Tbilisi State Medical University, where she studied Preventive Medicine (1996-2002). Her commitment to continuing education is evident from her participation in specialized courses, including the European Patients Academy (EUPATI) Expert Patients Course (2017-2018) and the EATG Training Academy’s STEP-UP program (2014-2015). This extensive educational background has equipped her with a robust understanding of public health, epidemiology, and the skills necessary to address complex health challenges effectively.

Professional Experience

Dr. Marine Gogia, a distinguished Public Health Specialist and Patient Advocate, has amassed extensive experience in public health, harm reduction, and infectious disease control. Currently a Programs Director at the Georgian Harm Reduction Network (GHRN), she leads critical projects such as the Global Fund initiative to prevent HIV/AIDS and minimize drug-related harm. Her role encompasses both management and research, with notable studies on HIV self-testing and Hepatitis C elimination. Dr. Gogia has also contributed as a Co-chair at the European AIDS Treatment Group (EATG), where she provides technical expertise and strategic direction. Her prior roles include consulting for WHO and the Global Fund, and serving as a Program Coordinator at Curatio International Foundation. Her work reflects a commitment to improving health outcomes and advocating for marginalized communities through rigorous research and strategic program implementation.

Research Interest

Dr. Marine Gogia’s research interests center around public health, with a particular focus on HIV/AIDS, harm reduction, and epidemiology. She is dedicated to advancing strategies for combating HIV and hepatitis C, especially among vulnerable populations such as people who inject drugs (PWID) and marginalized groups. Her work involves evaluating and improving harm reduction programs, assessing risky behaviors, and enhancing access to healthcare services through innovative research methodologies like simplified bio-behavioral surveillance surveys. Dr. Gogia is also actively involved in policy advocacy and capacity building, contributing to global health guidelines and strategies. Her research aims to bridge gaps in healthcare access and improve the effectiveness of public health interventions, with significant contributions to regional and international efforts in infectious disease control and prevention.

Research Skills

Dr. Marine Gogia possesses exceptional research skills demonstrated through her extensive experience in public health and epidemiology. Her expertise includes conducting bio-behavioral surveillance surveys, operational research, and evaluating HIV and hepatitis C testing and treatment programs. Dr. Gogia excels in designing and implementing research methodologies, such as the BSS-Lite survey, to assess risky behaviors among people who inject drugs (PWIDs). She is adept at analyzing data related to HIV self-testing acceptability and identifying barriers to HCV program enrollment. Her research skills are further evident in her contributions to studies on legal and regulatory barriers, and her ability to synthesize complex information into actionable insights for policy-making. Dr. Gogia’s proficiency extends to training and consultancy, where she effectively translates research findings into practical solutions for public health challenges. Her work consistently reflects a high level of analytical rigor and a commitment to advancing public health outcomes.

Awards and Recognition

Maryam has received several certificates of participation and training, including the Training of Trainers certificates, a peer reviewer course, and various certificates in statistical analysis and genetic research. These accolades demonstrate her commitment to continuous learning and professional development.

Conclusion

Maryam Qasim is a promising candidate for the Best Researcher Award due to her significant contributions to antimicrobial resistance research and molecular genetics. Her work, although primarily regional, has the potential to address broader health issues through applied research and collaborative efforts. Her academic background and continued professional development through various certifications further strengthen her candidacy.

Publications Top Notes

  1. Progress Toward the Elimination of Hepatitis B and Hepatitis C in the Country of Georgia, April 2015-April 2024
    • Authors: Tohme, R.A., Shadaker, S., Adamia, E., Schumacher, I.T., Gabunia, T.
    • Year: 2024
  2. Piloting a Simplified Bio-Behavioural Survey Methodology, the BBS-Lite, Among People Who Inject Drugs in Georgia
    • Authors: Gogia, M., Ruadze, E., Kasrashvili, T., Khonelidze, I., Stvilia, K.
    • Year: 2024
  3. Recommendations for Defining Preventable HIV-Related Mortality for Public Health Monitoring in the Era of Getting to Zero: An Expert Consensus
    • Authors: Croxford, S.E., Martin, V., Lucas, S.B., Waters, L.J., Sullivan, A.K.
    • Year: 2023
    • Citations: 1
  4. Barriers of Linkage to HCV Viremia Testing Among People Who Inject Drugs in Georgia
    • Authors: Butsashvili, M., Abzianidze, T., Kamkamidze, G., Nasrullah, M., Averhoff, F.
    • Year: 2022
    • Citations: 2
  5. Hidden Populations: Risk Behaviours in Drug-Using Populations in the Republic of Georgia Through Subsequent Peer-Driven Interventions
    • Authors: Lawlor, C., Gogia, M., Kirtadze, I., Jikia, G., Zurashvili, T.
    • Year: 2021
    • Citations: 1
  6. A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic
    • Authors: Farhoudian, A., Radfar, S.R., Ardabili, H.M., Yitayih, Y., Zhao, M.
    • Year: 2021
    • Citations: 44
  7. Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey
    • Authors: Radfar, S.R., De Jong, C.A.J., Farhoudian, A., Zhao, M., Zonoozi, A.K.
    • Year: 2021
    • Citations: 53
  8. Integration of Hepatitis C Treatment at Harm Reduction Centers in Georgia—Findings from a Patient Satisfaction Survey
    • Authors: Butsashvili, M., Kamkamidze, G., Kajaia, M., Japaridze, M., Averhoff, F.
    • Year: 2020
    • Citations: 9
  9. Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs — Georgia, 2018
    • Authors: Stvilia, K., Spradling, P.R., Asatiani, A., Averhoff, F., Nasrullah, M.
    • Year: 2019
    • Citations: 17
  10. Hidden Populations: Discovering the Differences Between the Known and the Unknown Drug-Using Populations in the Republic of Georgia
    • Authors: Gogia, M., Lawlor, C., Shengelia, N., Stvilia, K., Raymond, H.F.
    • Year: 2019
    • Citations: 1